Psyadon Pharma Raises $8 Million
Psyadon Pharmaceuticals Inc. (fka Ruxton Pharma), a Germantown, Md.-based CNS drug developer, has raised $8 million in Series A-1 funding from return backer New Enterprise Associates.
10 November 2008•2 mins read
Psyadon Pharmaceuticals Inc. (fka Ruxton Pharma), a Germantown, Md.-based CNS drug developer, has raised $8 million in Series A-1 funding from return backer New Enterprise Associates.
